Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure
|
journal
|
November 2003 |
Immunological mechanisms of allergen-specific immunotherapy
|
journal
|
October 2006 |
The role of allergy in the development of asthma
|
journal
|
November 1999 |
Intranasal CpG DNA therapy during allergen exposure in allergic rhinitis
|
journal
|
February 2007 |
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
|
journal
|
November 2013 |
PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration
|
journal
|
January 2011 |
Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism
|
journal
|
March 2011 |
CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma☆☆☆★
|
journal
|
December 1999 |
Synthesis of Pyridyl Disulfide-Functionalized Nanoparticles for Conjugating Thiol-Containing Small Molecules, Peptides, and Proteins
|
journal
|
April 2010 |
The cell biology of asthma
|
journal
|
June 2014 |
Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis
|
journal
|
September 2011 |
A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles
|
journal
|
May 2007 |
Therapeutic potential of Toll-like receptor 9 activation
|
journal
|
June 2006 |
Nanoparticles target distinct dendritic cell populations according to their size
|
journal
|
May 2008 |
The dendritic cell mannose receptor mediates allergen internalization and maturation involving notch 1 signalling: MR mediates allergen internalization and maturation of DC
|
journal
|
September 2010 |
Expression of Toll-like Receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis
|
journal
|
February 2007 |
Novel vaccines and adjuvants for allergen-specific immunotherapy
|
journal
|
December 2006 |
Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis
|
journal
|
October 2006 |
Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects
|
journal
|
January 2004 |
Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen
|
journal
|
September 2010 |
Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Allergy
|
journal
|
July 2014 |
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
|
journal
|
September 1997 |
Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice
|
journal
|
April 2013 |
TLR9-Based Immunotherapy for Allergic Disease
|
journal
|
October 2006 |
TLR3 but Not TLR7/8 Ligand Induces Allergic Sensitization to Inhaled Allergen
|
journal
|
April 2012 |
Systemic Administration of Olygodeoxynucleotides with CpG Motifs at Priming Phase Reduces Local Th2 Response and Late Allergic Rhinitis in BALB/c Mice
|
journal
|
September 2007 |
A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice
|
journal
|
January 2014 |
Allergy, Parasites, and the Hygiene Hypothesis
|
journal
|
April 2002 |
Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation
|
journal
|
August 2000 |
Size-Dependent Uptake of Particles by Pulmonary Antigen-Presenting Cell Populations and Trafficking to Regional Lymph Nodes
|
journal
|
July 2013 |
CpG oligonucleotide modulation of allergic inflammation
|
journal
|
May 2001 |
Immunotherapy of Allergic Rhinitis: New Therapeutic Opportunities with Virus-like Particles Filled with Cpg Motifs
|
journal
|
May 2013 |
CpG Still Rocks! Update on an Accidental Drug
|
journal
|
April 2012 |
Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis
|
journal
|
September 2004 |
Immunomodulatory Effects of CpG Oligodeoxynucleotides on Established Th2 Responses
|
journal
|
November 2002 |
Opportunities and challenges of the pulmonary route for vaccination
|
journal
|
March 2011 |
Immunotherapy of allergic diseases by bacterial products
|
journal
|
March 2011 |
Role of innate immunity in the pathogenesis of allergic rhinitis
|
journal
|
January 2012 |
Transforming growth factor β and severe asthma: A perfect storm
|
journal
|
October 2014 |
House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells
|
journal
|
March 2009 |
Pre-priming: a novel approach to DNA-based vaccination and immunomodulation
|
journal
|
March 2000 |
Use of CpG oligonucleotides in treatment of asthma and allergic disease
|
journal
|
March 2009 |
Orchestrating house dust mite-associated allergy in the lung
|
journal
|
September 2011 |
Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination
|
journal
|
October 2011 |
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
|
journal
|
January 2014 |
Eosinophils Are Dispensable for Allergic Remodeling and Immunity in a Model of House Dust Mite–induced Airway Disease
|
journal
|
January 2011 |
Intranasal Immunotherapy Is More Effective Than Intradermal Immunotherapy for the Induction of Airway Allergen Tolerance in Th2-Sensitized Mice
|
journal
|
April 2003 |
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs
|
journal
|
June 2014 |
Rapid translocation of nanoparticles from the lung airspaces to the body
|
journal
|
November 2010 |
Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study: Treatment of allergy with novel immunotherapeutic
|
journal
|
June 2011 |
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial
|
journal
|
April 2009 |
IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN
|
journal
|
March 2011 |
Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
|
journal
|
February 2014 |
Asthma protection with bacteria - science or fiction?
|
journal
|
May 2011 |
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway
|
journal
|
May 2013 |
Update in clinical allergy and immunology
|
journal
|
October 2012 |
Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma
|
journal
|
March 1998 |